Tandem Diabetes Care, Inc.

LSE:0M0F Stock Report

Market Cap: US$2.3b

Tandem Diabetes Care Past Earnings Performance

Past criteria checks 0/6

Tandem Diabetes Care's earnings have been declining at an average annual rate of -32.4%, while the Medical Equipment industry saw earnings declining at 5.9% annually. Revenues have been growing at an average rate of 23.4% per year.

Key information

-32.4%

Earnings growth rate

-26.5%

EPS growth rate

Medical Equipment Industry Growth-9.5%
Revenue growth rate23.4%
Return on equity-71.0%
Net Margin-29.8%
Next Earnings Update02 May 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Tandem Diabetes Care makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

LSE:0M0F Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23748-223352170
30 Sep 23771-208364163
30 Jun 23790-224355157
31 Mar 23795-204352148
31 Dec 22801-95336139
30 Sep 22791-68309133
30 Jun 22766-13290120
31 Mar 227386276107
31 Dec 217031626292
30 Sep 216612224580
30 Jun 21605723072
31 Mar 21542-2521467
31 Dec 20499-3420564
30 Sep 20439-4919659
30 Jun 20410-4219055
31 Mar 20394-1718050
31 Dec 19362-2516645
30 Sep 19330-2415241
30 Jun 19282-5513737
31 Mar 19223-11311933
31 Dec 18184-12310529
30 Sep 18148-1389426
30 Jun 18129-1198523
31 Mar 18116-828422
31 Dec 17108-738621
30 Sep 1796-768419
30 Jun 1782-908520
31 Mar 1783-878420
31 Dec 1684-838319
30 Sep 1684-818419
30 Jun 1688-708318
31 Mar 1681-728117
31 Dec 1573-727917
30 Sep 1562-797817
30 Jun 1559-797816
31 Mar 1554-797616
31 Dec 1450-807516
30 Sep 1442-856915
30 Jun 1436-786213
31 Mar 1432-745612
31 Dec 1329-634511
30 Sep 1321-483610
30 Jun 1313-43319

Quality Earnings: 0M0F is currently unprofitable.

Growing Profit Margin: 0M0F is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 0M0F is unprofitable, and losses have increased over the past 5 years at a rate of 32.4% per year.

Accelerating Growth: Unable to compare 0M0F's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 0M0F is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (17.9%).


Return on Equity

High ROE: 0M0F has a negative Return on Equity (-70.98%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.